Radicava ORS 105 MG/5 ML susp 50ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4D8Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,585
Award facts
- Contract value 100% obligated
- $46,584.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $46,584.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Radicava ORS (edaravone oral suspension) 105 mg/5 ml in 50ml quantities. The contract, issued on December 22, 2025, with an ultimate completion date of January 14, 2026, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order operates under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates consistent success in competing for open medical supply awards across multiple therapeutic domains, including specialty medications, vaccines, and medical devices that serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4D8Y?
SPE2DR26F4D8Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F4D8Y worth?
The government has obligated $46,585 on SPE2DR26F4D8Y.
Is contract SPE2DR26F4D8Y an order under another contract?
Yes. SPE2DR26F4D8Y is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4D8Y competed?
The extent of competition for SPE2DR26F4D8Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award